Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Acrofacialdysostosis, Weyers type (WAD) is a rare ectodermal dysplasia syndrome with bone abnormalities characterized by onychodystrophy; anomalies of the lower jaw, oral vestibule and dentition; post-axialpolydactyly; moderately restricted growth with short limbs; and normal intelligence. Although it closely resembles Ellis-van Creveld syndrome, an allelic disorder and another type of ciliopathy, WAD is usually a milder disease without the presence of heart abnormalities and is inherited in an autosomal dominant manner.
Features include: Prominent antihelix, Small nail, Short palm, and Brachydactyly and 8 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 3 | Postaxial hand polydactyly, Clinodactyly of the 5th finger, Postaxial foot polydactyly |
EVC encodes EvC ciliary complex subunit 1 (992 aa). Component of the EvC complex that positively regulates ciliary Hedgehog (Hh) signaling. Involved in endochondral growth and skeletal development Highest expression in Cells Cultured fibroblasts (40.5 TPM) and Ovary (35.4 TPM).
Acrofacial dysostosis, Weyers type is associated with mutations in the EVC gene on chromosome 4.
The EVC protein participates in GLI:SUFU translocates to the ciliary tip in response to Hh signaling pathway.
EVC is classified as a druggable target with score 13.1.
EVC2 encodes EvC ciliary complex subunit 2 (1,308 aa). Component of the EvC complex that positively regulates ciliary Hedgehog (Hh) signaling. Plays a critical role in bone formation and skeletal development. Highest expression in Ovary (15.1 TPM) and Cervix Ectocervix (12.5 TPM).
Acrofacial dysostosis, Weyers type is associated with mutations in the EVC2 gene on chromosome 4.
Genetic testing for EVC, EVC2 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for acrofacial dysostosis, Weyers type.
3 publications have been identified in PubMed for acrofacial dysostosis, Weyers type. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (33%), and Epidemiology / Natural History (33%).
Chen A (2026). [PMID: 41664038](https://pubmed.ncbi.nlm.nih.gov/41664038/). *BMC Med Genomics*. [Basic Science / Preclinical]
Liang C (2026). [PMID: 41810204](https://pubmed.ncbi.nlm.nih.gov/41810204/). *Transl Pediatr*. [Case Report / Case Series]
Altunoglu U (2024). [PMID: 38531627](https://pubmed.ncbi.nlm.nih.gov/38531627/). *J Med Genet*. [Epidemiology / Natural History]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 7:54 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acrofacial dysostosis, Weyers type
2 |
Small nail, Nail dysplasia |
Head and neck | 1 | Solitary median maxillary central incisor |
Growth and development | 1 | Mild short stature |
The EVC2 protein participates in GLI:SUFU translocates to the ciliary tip in response to Hh signaling pathway.
EVC2 is classified as a druggable target with score 0.0.